Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 1, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scholar Rock Holding Corp
| 13.5K |
—
|
—
| +252.86% | 18.84K |
Jun 27
| |||||||
Neumora Therapeutics, Inc.
| 20.1K |
—
|
—
| +72.78% | 47.72K |
Jun 13
| |||||||
Rapport Therapeutics, Inc.
| 3.73M |
—
|
—
|
∞
| 3.73M |
Jun 10
| |||||||
Rapport Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Boundless Bio, Inc.
| 2.63M |
$16.00 | $3,200,000.00 | +151.43% | 4.36M |
Apr 2
| |||||||
Boundless Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 27
| |||||||
Boundless Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Prime Medicine, Inc.
| 3.2M |
$6.25 | $20,000,000.00 |
∞
| 3.2M |
Feb 15
| |||||||
Sana Biotechnology, Inc.
| 1.82M |
$5.50 | $9,999,995.50 | +5.39% | 35.56M |
Feb 8
| |||||||
Scholar Rock Holding Corp
| -286.57K |
—
|
—
| -10.86% | 2.35M |
Dec 21
| |||||||
Neumora Therapeutics, Inc.
| 1.89M |
—
|
—
| +51.85% | 5.55M |
Dec 8
| |||||||
Neumora Therapeutics, Inc.
| 35.01K |
$11.77 | $412,139.61 | +0.85% | 4.13M |
Nov 13 - Nov 14
| |||||||
Neumora Therapeutics, Inc.
| 140.6K |
$10.98 | $1,543,563.42 | +3.55% | 4.1M |
Nov 8 - Nov 10
| |||||||
Neumora Therapeutics, Inc.
| 95.69K |
$11.49 | $1,099,944.70 | +2.48% | 3.96M |
Nov 3 - Nov 7
| |||||||
Neumora Therapeutics, Inc.
| 76.51K |
$13.68 | $1,046,848.16 | +2.02% | 3.86M |
Sep 28 - Sep 29
| |||||||
Neumora Therapeutics, Inc.
| 58.5K |
$11.97 | $700,464.24 | +1.57% | 3.78M |
Sep 26 - Sep 27
| |||||||
Neumora Therapeutics, Inc.
| 100.74K |
$11.19 | $1,127,063.95 | +2.78% | 3.72M |
Sep 22 - Sep 25
| |||||||
Neumora Therapeutics, Inc.
| 18.94M |
$17.00 |
—
| +178.31% | 29.56M |
Sep 19
| |||||||
Neumora Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 14
| |||||||
Neumora Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Da32 Life Science Tech Acquisition Corp.
| -1.60M |
—
|
—
| -100.00% |
0
|
Jul 28
| |||||||
Scholar Rock Holding Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Gossamer Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Prime Medicine, Inc.
| 12.26M |
$17.00 |
—
|
∞
| 12.26M |
Oct 24
| |||||||
Prime Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 1
| |||||||
Gossamer Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Scholar Rock Holding Corp
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
|
Aug 5
| |||||||
Da32 Life Science Tech Acquisition Corp.
| 2.25M |
$10.00 | $22,500,000.00 | +140.63% | 3.85M |
Jul 30
| |||||||
Da32 Life Science Tech Acquisition Corp.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Erasca, Inc.
| 11.06M |
—
|
—
|
∞
| 11.06M |
Jul 20
| |||||||
Erasca, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Beam Therapeutics Inc.
| -397.99K |
—
|
—
| -6.36% | 5.86M |
Jun 30
| |||||||
Beam Therapeutics Inc.
| -795.98K |
—
|
—
| -7.68% | 9.57M |
Jun 25 - Jun 29
| |||||||
Unity Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Verve Therapeutics, Inc.
| 2.51M |
—
|
—
|
∞
| 2.51M |
Jun 21
| |||||||
Verve Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Beam Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.